Research

Lutein, zeaxanthin, and meso-zeaxanthin supplementation attenuates inflammatory cytokines and markers of oxidative cardiovascular processes in humans. (LIFE Study).

Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer’s Disease. (re-MIND Trial)

Omega-3 Fatty Acid, Carotenoid and Vitamin E Supplementation Improves Working Memory in Older Adults: A Randomised Clinical Trial. (CARES Trial 2)

Supplementation with the Macular Carotenoids in Alzheimer’s Disease: Response and Safety Data. (CREST Cognition Study).

The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial (CREST AMD STUDY)

Prevalence of age-related macular degeneration in the Republic of Ireland. (TILDA Study).

The impact of supplemental macular carotenoids in Alzheimer’s disease: A randomized Clinical Trial. (CARDS Study 2).

Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration. (MOST AMD Study)

Macular pigment, visual function, and macular disease among subjects with Alzheimer’s disease: An Exploratory Study. (CARDS Study 1).

Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults. (TILDA Study)

Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment. (Central Dip Study)

Supplementation with All Three Macular Carotenoids: Response, Stability, and Safety — Second Publication in the Series of Meso-Zeaxanthin Ocular Supplementation with All Three Macular Carotenoids: Response, Stability, and Safety. (MOST Trial 2)

Augmentation of Macular Pigment Following Supplementation with All Three Macular Carotenoids: An Exploratory Study. (MOST Trial 1)